Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
Esperovax, a leading developer of oral vaccines, announced it has signed a new, exclusive licensing agreement with Innovation Partners at the University of Michigan...
Cipla Limited and its wholly owned subsidiary Cipla USA Inc. (hereafter referred to as 'Cipla'), announced the launch of Leuprolide Acetate Injection Depot 22.5mg....
Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-expressed protein therapeutics, today announced it has...
